Literature DB >> 33797005

More than the oocyte source, egg donors as patients: a national picture of United States egg donors.

Jennifer F Kawwass1, Patrick Ten Eyck2, Patrick Sieber3, Heather S Hipp4, Brad Van Voorhis5.   

Abstract

PURPOSE: To characterize national oocyte donation practice patterns from the perspective of individual donors rather than of recipients.
METHODS: Retrospective cohort including all donor oocyte retrievals and transfers reported to SARTCORS in 2016 and 2017 in the USA. Primary outcomes include characteristics of oocyte donors and of donor oocyte cycles. Secondary outcomes include overall pregnancy rates, elective single embryo transfer (eSET) rates, and perinatal outcomes among donor oocyte recipient transfers.
RESULTS: During the study period, 49,193 donor oocyte retrievals were performed, of which the largest proportion were in the Western US. For all reported retrievals, there were 17,099 unique donors, each of whom underwent an average of 2.4 retrievals (range 1-22). Average donor age was 26.3 years (range 18-48). On average, 24.6 oocytes (SD 12.4) were retrieved each cycle, ranging from 0 to 102. Among 37,657 donor oocyte recipient transfers, 20,159 (53.5%) involved eSET, and 17,725 (47.1%) resulted in live birth. Miscarriage rates were 17.5%, and good perinatal outcome (GPO), defined as full-term normal birthweight delivery, was more likely among singleton (75.7%) than multiple (23.8%) pregnancies.
CONCLUSION: The average number of retrievals that donors underwent and oocyte yield mirrored national guidelines; however outliers, exist that may unnecessarily increase donor risk. Additionally, among resultant donor transfers, 46.5% transferred more than one embryo despite national recommendations for eSET. The significantly higher likelihood of GPO among singleton pregnancies points to the need to further increase donor recipient eSET rates.

Entities:  

Keywords:  Characteristics; Egg donor; National outcomes; Oocyte donation; eSET

Mesh:

Year:  2021        PMID: 33797005      PMCID: PMC8190211          DOI: 10.1007/s10815-021-02178-1

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  12 in total

1.  Guidance on the limits to the number of embryos to transfer: a committee opinion.

Authors: 
Journal:  Fertil Steril       Date:  2017-03-11       Impact factor: 7.329

2.  Pregnancy rates in donor oocyte cycles compared to similar autologous in vitro fertilization cycles: an analysis of 26,457 fresh cycles from the Society for Assisted Reproductive Technology.

Authors:  Jason S Yeh; Ryan G Steward; Annie M Dude; Anish A Shah; James M Goldfarb; Suheil J Muasher
Journal:  Fertil Steril       Date:  2014-05-17       Impact factor: 7.329

3.  Repetitive oocyte donation: a committee opinion.

Authors: 
Journal:  Fertil Steril       Date:  2014-07-23       Impact factor: 7.329

Review 4.  Third-party reproduction in the Internet Age: the new, patient-centered landscape.

Authors:  Julia T Woodward
Journal:  Fertil Steril       Date:  2015-06-24       Impact factor: 7.329

5.  Predicting the likelihood of live birth for elective oocyte cryopreservation: a counseling tool for physicians and patients.

Authors:  R H Goldman; C Racowsky; L V Farland; S Munné; L Ribustello; J H Fox
Journal:  Hum Reprod       Date:  2017-04-01       Impact factor: 6.918

6.  Do donor oocyte cycles comply with ASRM/SART embryo transfer guidelines? An analysis of 13,393 donor cycles from the SART registry.

Authors:  Kelly S Acharya; Sanaz Keyhan; Chaitanya R Acharya; Jason S Yeh; Meredith P Provost; James M Goldfarb; Suheil J Muasher
Journal:  Fertil Steril       Date:  2016-05-13       Impact factor: 7.329

7.  Repetitive oocyte donation does not decrease serum anti-Müllerian hormone levels.

Authors:  Orhan Bukulmez; Qin Li; Bruce R Carr; Benjamin Leader; Kathleen M Doody; Kevin J Doody
Journal:  Fertil Steril       Date:  2009-07-23       Impact factor: 7.329

8.  Donor oocyte recipients do not benefit from preimplantation genetic testing for aneuploidy to improve pregnancy outcomes.

Authors:  Nicole Doyle; Michelle Gainty; Allison Eubanks; Joseph Doyle; Heidi Hayes; Michael Tucker; Kate Devine; Alan DeCherney; Michael Levy; Samad Jahandideh; Micah Hill
Journal:  Hum Reprod       Date:  2020-11-01       Impact factor: 6.918

9.  Effect of oocyte donor stimulation on recipient outcomes: data from a US national donor oocyte bank.

Authors:  H S Hipp; A J Gaskins; Z P Nagy; S M Capelouto; D B Shapiro; J B Spencer
Journal:  Hum Reprod       Date:  2020-04-28       Impact factor: 6.918

10.  Total follicle stimulating hormone dose is negatively correlated with live births in a donor/recipient model with fresh transfer: an analysis of 8,627 cycles from the Society for Assisted Reproductive Technology Registry.

Authors:  Kathryn L Shaia; Kelly S Acharya; Benjamin S Harris; Jeremy M Weber; Tracy Truong; Suheil J Muasher
Journal:  Fertil Steril       Date:  2020-06-17       Impact factor: 7.329

View more
  1 in total

Review 1.  Fertility after Curative Therapy for Sickle Cell Disease: A Comprehensive Review to Guide Care.

Authors:  Robert Sheppard Nickel; Jacqueline Y Maher; Michael H Hsieh; Meghan F Davis; Matthew M Hsieh; Lydia H Pecker
Journal:  J Clin Med       Date:  2022-04-21       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.